Natera Inc (NTRA) - Total Assets
Based on the latest financial reports, Natera Inc (NTRA) holds total assets worth $2.66 Billion USD as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Natera Inc - Total Assets Trend (2012–2025)
This chart illustrates how Natera Inc's total assets have evolved over time, based on quarterly financial data. Also see NTRA stock market capitalisation for the company's overall valuation and market capitalisation.
Natera Inc - Asset Composition Analysis
Current Asset Composition (December 2025)
Natera Inc's total assets of $2.66 Billion consist of 59.7% current assets and 40.3% non-current assets. Review NTRA current and long-term liabilities to assess the company's total debt and financial obligations.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 42.9% |
| Accounts Receivable | $296.53 Million | 11.8% |
| Inventory | $68.44 Million | 2.7% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $373.71 Million | 14.9% |
| Goodwill | $141.07 Million | 5.6% |
Asset Composition Trend (2012–2025)
This chart illustrates how Natera Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See Natera Inc stock price for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Natera Inc's current assets represent 59.7% of total assets in 2025, a decrease from 67.8% in 2012.
- Cash Position: Cash and equivalents constituted 42.9% of total assets in 2025, down from 43.4% in 2012.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 19.0% of total assets, an increase from 0.0% in 2012.
- Asset Diversification: The largest asset category is intangible assets at 14.9% of total assets.
Natera Inc Competitors by Total Assets
Key competitors of Natera Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Australian Clinical Labs Ltd
AU:ACL
|
Australia | AU$562.50 Million |
|
Monash Ivf Group Ltd
AU:MVF
|
Australia | AU$512.35 Million |
|
INOVIQ LTD.
F:EGQ0
|
Germany | €21.71 Million |
|
Sonic Healthcare Ltd
AU:SHL
|
Australia | AU$16.78 Billion |
|
Integral Diagnostics Ltd
AU:IDX
|
Australia | AU$1.43 Billion |
|
Healius Ltd
AU:HLS
|
Australia | AU$1.77 Billion |
|
Cryosite Ltd
AU:CTE
|
Australia | AU$26.55 Million |
|
Microba Life Sciences Ltd
AU:MAP
|
Australia | AU$43.35 Million |
Natera Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.00 | 3.72 | 5.96 |
| Quick Ratio | 2.85 | 3.58 | 5.82 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $1.11 Billion | $1.05 Billion | $991.51 Million |
Natera Inc - Advanced Valuation Insights
This section examines the relationship between Natera Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 26.14 |
| Latest Market Cap to Assets Ratio | 18.74 |
| Asset Growth Rate (YoY) | 51.0% |
| Total Assets | $2.51 Billion |
| Market Capitalization | $47.01 Billion USD |
Valuation Analysis
Premium Asset Valuation: The market values Natera Inc's assets at a significant premium (18.74x), suggesting investors see substantial growth potential or unique competitive advantages.
Rapid Asset Growth: Natera Inc's assets grew by 51.0% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Natera Inc (2012–2025)
The table below shows the annual total assets of Natera Inc from 2012 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $2.51 Billion | +51.02% |
| 2024-12-31 | $1.66 Billion | +15.19% |
| 2023-12-31 | $1.44 Billion | +3.39% |
| 2022-12-31 | $1.39 Billion | +12.78% |
| 2021-12-31 | $1.24 Billion | +32.65% |
| 2020-12-31 | $932.15 Million | +59.98% |
| 2019-12-31 | $582.66 Million | +117.27% |
| 2018-12-31 | $268.17 Million | +24.96% |
| 2017-12-31 | $214.61 Million | +1.87% |
| 2016-12-31 | $210.68 Million | -20.57% |
| 2015-12-31 | $265.24 Million | +114.56% |
| 2014-12-31 | $123.62 Million | +106.99% |
| 2013-12-31 | $59.72 Million | +349.28% |
| 2012-12-31 | $13.29 Million | -- |
About Natera Inc
Natera, Inc., a diagnostics company, engages in the development and commercialization of molecular testing services worldwide. It offers Signatera, a personalized ctDNA blood test for MRD assessment, early recurrence monitoring, and evaluation of treatment response in patients previously diagnosed with cancer; Latitude, a blood-based MRD test for colorectal cancer; Altera, a tissue based comprehe… Read more